MedPath

Home-Based Exercise Program For Recovery After Transcatheter Aortic Valve Replacement

Not Applicable
Completed
Conditions
Aortic Valve Stenosis
Registration Number
NCT02805309
Lead Sponsor
Brigham and Women's Hospital
Brief Summary

Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure for older adults with severe symptomatic aortic stenosis who are considered high risk for surgical aortic valve replacement. Despite symptomatic and survival benefits, many patients experience functional decline after TAVR. This pilot study aims to test the feasibility of a home-based exercise intervention targeting endurance, strength, and balance as well as cognitive behavioral intervention to improve physical functioning and disability after TAVR.

Detailed Description

We hypothesize that a home-based exercise program with cognitive behavioral intervention is more effective than home-based exercise alone; home-based exercise program with and without cognitive behavioral intervention is more effective than attention control educational intervention in preventing decline in physical function and disability after TAVR.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
64
Inclusion Criteria
  • Age ≥ 65 years
  • Underwent transcatheter aortic valve replacement
  • Lives within 20-mile radius of the recruiting site
  • Plan to be discharged home
  • Able to provide informed consent
Exclusion Criteria
  • Stroke or any other medical disease that precludes participation in the exercise program
  • Severe cognitive impairment (Mini-Mental State Examination < 15)
  • Current enrollment in another clinical trial

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in the Late-Life Function and Disability Instrument (LLFDI) ScoreAt baseline and week 8

The LLFDI is a validated patient-reported outcome questionnaire that measures both functional limitations (inability to perform physical tasks - Activity Limitation Domain score, range: 0-100) and disability (inability to perform major life tasks and social roles - Participation Restriction Domain score, range: 0-100). For both scales, higher values indicate better function (lower limitation or lower disability). Two domain scores are analyzed separately.

Secondary Outcome Measures
NameTimeMethod
Change in the Short Physical Performance Battery (SPPB) Summary ScoreAt baseline and week 8

The summary score is calculated based on chair stands, walking speed, and standing balance (range: 0-12). Higher scores indicate better physical performance.

Number of Participants Who Experienced Adverse EventsAt week 8

Number of participants who experience any adverse events and serious adverse events

Change in Dominant Hand Grip Strength (kg)At baseline and week 8

Dominant hand grip strength measures upper extremity strength.

Change in the 2-Minute Walk Distance (Feet)At baseline and week 8

The 2-minute walk distance measures endurance. A longer distance indicates better endurance.

Trial Locations

Locations (3)

Brigham and Women's Hospital

🇺🇸

Boston, Massachusetts, United States

Hebrew SeniorLife

🇺🇸

Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center

🇺🇸

Boston, Massachusetts, United States

Brigham and Women's Hospital
🇺🇸Boston, Massachusetts, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.